Safety study of AZD7760 in healthy Japanese adults
Part of Infections clinical trials.
This is a Phase 1 safety study of a new investigational drug called AZD7760 in healthy Japanese volunteers. The trial will test how the body handles the drug and monitor for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy Japanese adult with no significant medical conditions or chronic medications
- Your weight must be between 45–110 kg (99–242 lbs) and BMI between 18.0–30.0
- Your liver, kidney, and blood cell function must be normal at screening
- You cannot have a history of serious allergies to monoclonal antibody drugs or severe reactions after injections or blood draws
- You must not have donated blood recently (within 4 weeks) or have received immunosuppressive therapy
- You must have suitable veins for blood sampling and study drug administration
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This trial tests a new drug called AZD7760 in two groups: healthy adults (Phase I) and adults with end-stage kidney disease who are on hemodialysis through a central venous catheter (Phase IIa). The goal is to see how safe the drug is and how the body processes it. This could lead to a new treatment option for people on dialysis.
This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
Hear when a new Staphylococcus Aureus Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.